Source: Gener8 Blog

Gener8 Blog Microfluidic-Based POC Device for Detection and Analysis of HIV Directly From Blood

Microfluidic-Based POC Device for Detection and Analysis of HIV Directly From Blood Client/Summary Chipcare, a biotech company specializing in multiplexed Point-of-Care (POC) diagnostics for sexually transmitted infections, approached Gener8 to develop a turnkey sample-to-answer POC device and microfluidic-based cartridge for analyzing blood from HIV patients. The goal was to create a diagnostic device that would...The post Microfluidic-Based POC Device for Detection and Analysis of HIV Directly From Blood appeared first on Gener8.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Jerry Jurkiewicz's photo - CEO of Gener8

CEO

Jerry Jurkiewicz

CEO Approval Rating

90/100

Read more